MedPath

Vaxxinity, Inc.

Vaxxinity, Inc. logo
🇺🇸United States
Ownership
Public
Employees
57
Market Cap
$6.3M
Website
http://www.vaxxinity.com

AC Immune's ACI-7104 Shows Promise in Phase II Parkinson's Disease Trial

AC Immune's stock surged by over 20% following positive interim data from its Phase II VacSYn trial of ACI-7104.056 for Parkinson's disease.

© Copyright 2025. All Rights Reserved by MedPath